Verrica Pharmaceuticals Inc. Due to Related Parties, Current
Verrica Pharmaceuticals Inc. (VRCA) had Due to Related Parties, Current of $6.00 thousand as of 2019-06-30, per its 10-Q filed 2019-08-07.
Discontinued › Notes
us-gaap:DueToRelatedPartiesCurrent · last filed 2020-03-13
- 2019-06-30: Due to Related Parties, Current $6.00K.
- 2018-12-31: Due to Related Parties, Current $38.00K.
- 2018-09-30: Due to Related Parties, Current $38.00K.
- 2018-06-30: Due to Related Parties, Current $36.00K.
| Period end | Due to Related Parties, Current |
|---|---|
| 2019-06-30 | $6.00K 10-Q · filed 2019-08-07 |
| 2018-12-31 | $38.00K 10-K · filed 2020-03-13 |
| 2018-09-30 | $38.00K 10-Q · filed 2018-11-07 |
| 2018-06-30 | $36.00K 10-Q · filed 2018-08-07 |
| 2017-12-31 | $14.00K 10-K · filed 2019-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |